Article
Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir.
Internal medicine (Tokyo, Japan) - 1 Jul 2021
Totsuka Mai, Honda Masayuki, Kanda Tatsuo, Ishii Tomotaka, Matsumoto Naoki, Yamana Yoichiro, Kaneko Tomohiro, Mizutani Taku, Takahashi Hiroshi, Kumagawa Mariko, Sasaki Reina, Masuzaki Ryota, Kanezawa Shini, Nirei Kazushige, Yamagami Hiroaki, Matsuoka Shunichi, Ohnishi Hiroshi, Okamoto Hiroaki, Moriyama Mitsuhiko
Abstract excerpt
A 74-year-old man with a history of transfusion at 35 years old in Egypt was referred to our hospital. He was infected with hepatitis C virus (HCV) genotype 4 (GT4), which is a rare HCV GT in Japan, and was also diagnosed with hepatic compensated cirrhosis. We safely treated the patient for 12 weeks with the combination of glecaprevir and pibrentasvir, and a sustained virologic response (SVR) was achieved. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.